Buscar
Mostrando ítems 61-70 de 152
Chronic hepatitis C: hepatic iron content does not correlate with response to antiviral therapy
(Instituto de Medicina Tropical, 2009-12-01)
The complex interaction between hepatitis C virus infection, iron homeostasis and the response to antiviral treatment remains controversial. The aim of this study was to evaluate the influence of hepatic iron concentration ...
Predictive value of FIB-4 and APRI versus METAVIR on sustained virologic response in genotype 1 hepatitis C patients
(Springer, 2014-01-01)
Advanced liver fibrosis is a negative predictor of virologic response in genotype 1 chronic hepatitis C (CHC) patients. Biopsy, however, is invasive, costly, and carries some risk of complications.Using data from the ...
Efficacy and safety of peginterferon lambda for Covid-19, indications of a new antiviralEficacia y seguridad del peginterferón lambda para la Covid-19, indicios de un nuevo antiviral
(Boletín de Malariología y Salud Ambiental, 2021)
Introduction: Interferons are a family of cytokines that act on the innate immune response of the respiratory epithelium, a site of widespread viral invasion such as SARS-CoV-2. Objective: to analyze the published medical ...
Psychosis during peginterferon-alpha2a and ribavirin therapy: case report
(Brazilian Society of Infectious Diseases, 2006-12-01)
Pegylated Interferon-alpha, combined with ribavirin, gives high sustained virological response in patients with hepatitis C virus, an important public health problem and one of the most frequent chronic infectious diseases ...
Psychosis During Peginterferon-α2a and Ribavirin Therapy: Case Report
(2006)
Pegylated Interferon-alpha, combined with ribavirin, gives high sustained virological response in patients with hepatitis C virus, an important public health problem and one of the most frequent chronic infectious diseases ...
Prospective evaluation of peginterferon alfa-2a (40KD)/ribavirin in CHC, IFN/ribavirin nonresponders/relapsers
(Elsevier B.V., 2003-04-01)
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in children and adolescents
(ELSEVIER SCIENCE BV, 2010)
Background & Aims: This multi-center study aimed to prospectively evaluate the safety and efficacy of a genotype-based Pegylated Interferon alfa-2a/Ribavirin therapy in treatment-naive hepatitis C virus (HCV), positive HCV ...